Contracts Finder · Planning

2025+ Covid Vaccine Procurement

A public procurement published by UKHSA via Contracts Finder.

Contracts FinderPlanning
Award value
Tender value
0
Suppliers
0
Awards
2
Notices
Planning
Stage

Overview

UK Health Security Agency is inviting suppliers to participate in a market engagement activity to help inform and shape our approach to the future procurement of COVID-19 vaccines. During the pandemic, contracts were agreed with a number of suppliers to meet the need for urgency and high volume of vaccines required to protect the population. These contracts come to an end in 2024 and as we move into an endemic phase of the disease, we are considering how best to meet our vaccine demand requirements in the future. The objective of future procurements will be to match supply to the particular requirements of the planned vaccination programme at the time, such as the current variant(s)…

Key details

Buyer
UKHSA
Source
Contracts Finder
Lifecycle stage
Planning
Status
planning
CPV classification
33651600 — Vaccines
Currency
GBP
Total award value
Tender value
First published
17 Nov 2023
Last updated
17 Nov 2023
View the original notice

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Planning notice2025+ Covid Vaccine Procurement
  2. Planning notice2025+ Covid Vaccine Procurement

Frameworks & programmes

More from UKHSA

FAQs about this procurement

Who is the buyer for "2025+ Covid Vaccine Procurement"?

2025+ Covid Vaccine Procurement is a UK public-sector procurement published by UKHSA via Contracts Finder.

Has "2025+ Covid Vaccine Procurement" been awarded?

No award has been recorded yet. The current lifecycle stage is "Planning".

When was "2025+ Covid Vaccine Procurement" published?

It was first published on 17 Nov 2023 and last updated on 17 Nov 2023, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable